ABOUT US
NEUVOGEN is an immuno-oncology company applying a systems approach to develop therapeutic whole cell cancer vaccines to transform how cancer is treated.
SCIENCE
The NEUVOGEN platform represents the next generation in therapeutic whole cell cancer vaccines.
PIPELINE
NEUVOGEN’s research programs focus on therapeutic cancer vaccines to treat a wide range of tumor types across numerous solid tumor indications.